Thursday 9/30 Insider Buying Report: SVRA, AXDX

Thursday 9/30 Insider Buying Report: SVRA, AXDX

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money.

Today we look at two noteworthy recent insider buys.

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money.

Today we look at two noteworthy recent insider buys.

At Savara, a filing with the SEC revealed that on Thursday, Director David A.

Ramsay purchased 137,052 shares of SVRA, for a cost of $1.29 each, for a total investment of $176,382.

Savara is trading up about 7.1% on the day Thursday.

Before this latest buy, Ramsay bought SVRA at 2 other times during the past twelve months, for a total investment of $1.12M at an average of $1.42 per share.

And on Monday, Director Hany Massarany bought $53,000 worth of Accelerate Diagnostics, buying 10,000 shares at a cost of $5.30 each.

This buy marks the first one filed by Massarany in the past twelve months.

Accelerate Diagnostics is trading off about 1% on the day Thursday.

Massarany was up about 15.8% on the buy at the high point of today's trading session, with AXDX trading as high as $6.14 in trading on Thursday.